{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:23:04Z","timestamp":1794936184153,"version":"4.9.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI18C1629"],"award-info":[{"award-number":["HI18C1629"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI18C0335"],"award-info":[{"award-number":["HI18C0335"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI19C1132"],"award-info":[{"award-number":["HI19C1132"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2018R1A1A3A04079255"],"award-info":[{"award-number":["NRF-2018R1A1A3A04079255"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The retina and the brain share anatomic, embryologic, and physiologic characteristics. Therefore, retinal imaging in patients with brain disorders has been of significant interest. Using optical coherence tomography angiography (OCTA), a novel quantitative method of measuring retinal vasculature, we aimed to evaluate radial peripapillary capillary (RPC) network density and retinal nerve fiber layer (RNFL) thickness in cognitively impaired patients and determine their association with brain imaging markers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this prospective cross-sectional study, a total of 69 patients (138 eyes) including 29 patients with amyloid-positive Alzheimer\u2019s disease-related cognitive impairment (ADCI), 25 patients with subcortical vascular cognitive impairment (SVCI), and 15 amyloid-negative cognitively normal (CN) subjects were enrolled. After excluding eyes with an ophthalmologic disease or poor image quality, 117 eyes of 60 subjects were included in the final analyses. Retinal vascular [capillary density (CD) of the radial peripapillary capillary (RPC) network] and neurodegeneration markers [retinal nerve fiber layer (RNFL) thickness at four quadrants] were measured using OCTA and OCT imaging. Brain vascular (CSVD score) and neurodegeneration markers (cortical thickness) were assessed using 3D brain magnetic resonance imaging. The CD and RNFL thickness and their correlation with brain imaging markers were investigated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The SVCI group showed lower CD in the temporal quadrant of the RPC network compared to the CN group (mean (SD), 42.34 (6.29) vs 48.45 (7.08); <jats:italic>p<\/jats:italic>\u2009=\u20090.001). When compared to the ADCI group, the SVCI showed lower CD in the superior quadrant (mean (SD), 60.14 (6.42) vs 64.15 (6.39); <jats:italic>p<\/jats:italic>\u2009=\u20090. 033) as well as in the temporal quadrant (ADCI 45.76, SVCI 42.34; <jats:italic>p<\/jats:italic>\u2009=\u20090.048) of the RPC network. The CD was negatively correlated with CSVD score in the superior (B (95%CI), \u2212\u20090.059 (\u2212\u20090.097 to \u2212\u20090.021); <jats:italic>p<\/jats:italic>\u2009=\u20090.003) and temporal (B (95%CI), \u2212\u20090.048 (\u2212\u20090.080 to \u2212\u20090.017); <jats:italic>p<\/jats:italic>\u2009=\u20090.003) quadrants of the RPC network. RNFL thickness did not differ among the groups nor did it correlate with cortical thickness.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions and relevance<\/jats:title>\n                <jats:p>The microvasculature of the RPC network was related to the CSVD burden. However, the RNFL thickness did not reflect cerebral neurodegeneration. Noninvasive and rapid acquisition of the OCTA image might have the potential to be used as a screening tool to detect CSVD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-020-00638-x","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T15:04:23Z","timestamp":1591887863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Optical coherence tomography angiography as a potential screening tool for cerebral small vessel diseases"],"prefix":"10.1186","volume":"12","author":[{"given":"Ju-Yeun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Pyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyemin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hee","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duk L.","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Won","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei Yeul","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,11]]},"reference":[{"key":"638_CR1","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/S0140-6736(13)60221-4","volume":"381","author":"KY Chan","year":"2013","unstructured":"Chan KY, Wang W, Wu JJ, et al. Epidemiology of Alzheimer\u2019s disease and other forms of dementia in China, 1990-2010: a systematic review and analysis. Lancet. 2013;381:2016\u201323.","journal-title":"Lancet"},{"key":"638_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/msj.20157","volume":"77","author":"DP Perl","year":"2010","unstructured":"Perl DP. Neuropathology of Alzheimer\u2019s disease. Mt Sinai J Med. 2010;77:32\u201342.","journal-title":"Mt Sinai J Med"},{"key":"638_CR3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neuropharm.2017.12.030","volume":"134","author":"RN Kalaria","year":"2018","unstructured":"Kalaria RN. The pathology and pathophysiology of vascular dementia. Neuropharmacology. 2018;134:226\u201339.","journal-title":"Neuropharmacology"},{"key":"638_CR4","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.clineuro.2011.02.014","volume":"113","author":"A Kesler","year":"2011","unstructured":"Kesler A, Vakhapova V, Korczyn AD, Naftaliev E, Neudorfer M. Retinal thickness in patients with mild cognitive impairment and Alzheimer\u2019s disease. Clin Neurol Neurosurg. 2011;113:523\u20136.","journal-title":"Clin Neurol Neurosurg"},{"key":"638_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/WNO.0b013e318267fd5f","volume":"33","author":"S Kirbas","year":"2013","unstructured":"Kirbas S, Turkyilmaz K, Anlar O, Tufekci A, Durmus M. Retinal nerve fiber layer thickness in patients with Alzheimer disease. J Neuroophthalmol. 2013;33:58\u201361.","journal-title":"J Neuroophthalmol"},{"key":"638_CR6","first-page":"173","volume":"31","author":"BH Kang","year":"2013","unstructured":"Kang BH, Kim JI. Decreased retinal thickness in patients with Alzheimer\u2019s disease. J Korean Neurol Assoc. 2013;31:173\u20137.","journal-title":"J Korean Neurol Assoc"},{"key":"638_CR7","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1007\/s00415-014-7374-z","volume":"261","author":"FJ Ascaso","year":"2014","unstructured":"Ascaso FJ, Cruz N, Modrego PJ, et al. Retinal alterations in mild cognitive impairment and Alzheimer\u2019s disease: an optical coherence tomography study. J Neurol. 2014;261:1522\u201330.","journal-title":"J Neurol"},{"key":"638_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neulet.2007.02.090","volume":"420","author":"C Paquet","year":"2007","unstructured":"Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer\u2019s disease. Neurosci Lett. 2007;420:97\u20139.","journal-title":"Neurosci Lett"},{"key":"638_CR9","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1167\/iovs.06-1029","volume":"48","author":"F Berisha","year":"2007","unstructured":"Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL. Retinal abnormalities in early Alzheimer\u2019s disease. Invest Ophthalmol Vis Sci. 2007;48:2285\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"638_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JAD-141659","volume":"45","author":"C CY-l","year":"2015","unstructured":"CY-l C, Ong YT, Hilal S, et al. Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer\u2019s disease. J Alzheimers Dis. 2015;45:45\u201356.","journal-title":"J Alzheimers Dis"},{"key":"638_CR11","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3233\/JAD-132039","volume":"40","author":"M Gharbiya","year":"2014","unstructured":"Gharbiya M, Trebbastoni A, Parisi F, et al. Choroidal thinning as a new finding in Alzheimer\u2019s disease: evidence from enhanced depth imaging spectral domain optical coherence tomography. J Alzheimers Dis. 2014;40:907\u201317.","journal-title":"J Alzheimers Dis"},{"key":"638_CR12","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.ophtha.2013.12.023","volume":"121","author":"ES Garcia-Martin","year":"2014","unstructured":"Garcia-Martin ES, Rojas B, Ramirez AI, et al. Macular thickness as a potential biomarker of mild Alzheimer\u2019s disease. Ophthalmology. 2014;121:1149\u20131151. e1143.","journal-title":"Ophthalmology"},{"key":"638_CR13","doi-asserted-by":"publisher","first-page":"636548","DOI":"10.1155\/2015\/636548","volume":"2015","author":"E Salobrar-Garcia","year":"2015","unstructured":"Salobrar-Garcia E, Hoyas I, Leal M, et al. Analysis of retinal peripapillary segmentation in early Alzheimer\u2019s disease patients. Biomed Res Int. 2015;2015:636548.","journal-title":"Biomed Res Int"},{"key":"638_CR14","doi-asserted-by":"publisher","first-page":"16345","DOI":"10.1038\/s41598-018-34577-3","volume":"8","author":"D S\u00e1nchez","year":"2018","unstructured":"S\u00e1nchez D, Castilla-Marti M, Rodr\u00edguez-G\u00f3mez O, et al. Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer\u2019s disease. Sci Rep. 2018;8:16345.","journal-title":"Sci Rep"},{"key":"638_CR15","doi-asserted-by":"publisher","unstructured":"van de Kreeke JA, Nguyen H-T, den Haan J, et al. Retinal layer thickness in preclinical Alzheimer\u2019s disease. Acta Ophthalmologica. 2019. https:\/\/doi.org\/10.1111\/aos.14121.","DOI":"10.1111\/aos.14121"},{"key":"638_CR16","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1093\/brain\/awq127","volume":"133","author":"N Cheung","year":"2010","unstructured":"Cheung N, Mosley T, Islam A, et al. Retinal microvascular abnormalities and subclinical magnetic resonance imaging brain infarct: a prospective study. Brain. 2010;133:1987\u201393.","journal-title":"Brain"},{"key":"638_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1001\/jama.288.1.67","volume":"288","author":"TY Wong","year":"2002","unstructured":"Wong TY, Klein R, Sharrett AR, et al. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA. 2002;288:67\u201374.","journal-title":"JAMA"},{"key":"638_CR18","doi-asserted-by":"publisher","first-page":"6320","DOI":"10.1038\/s41598-019-42534-x","volume":"9","author":"S McGrory","year":"2019","unstructured":"McGrory S, Ballerini L, Doubal FN, et al. Retinal microvasculature and cerebral small vessel disease in the Lothian Birth Cohort 1936 and Mild Stroke Study. Sci Rep. 2019;9:6320.","journal-title":"Sci Rep"},{"key":"638_CR19","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00417-016-3430-y","volume":"254","author":"JP Cunha","year":"2016","unstructured":"Cunha JP, Moura-Coelho N, Proenca RP, et al. Alzheimer\u2019s disease: a review of its visual system neuropathology. Optical coherence tomography-a potential role as a study tool in vivo. Graefe\u2019s Arch Clin Exp Ophthalmol. 2016;254:2079\u201392.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"638_CR20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jns.2018.10.025","volume":"396","author":"NY Jung","year":"2019","unstructured":"Jung NY, Han JC, Ong YT, et al. Retinal microvasculature changes in amyloid-negative subcortical vascular cognitive impairment compared to amyloid-positive Alzheimer\u2019s disease. J Neurol Sci. 2019;396:94\u2013101.","journal-title":"J Neurol Sci"},{"key":"638_CR21","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1161\/STROKEAHA.110.580837","volume":"41","author":"H Yatsuya","year":"2010","unstructured":"Yatsuya H, Folsom AR, Wong TY, Klein R, Klein BE, Sharrett AR. Retinal microvascular abnormalities and risk of lacunar stroke: Atherosclerosis Risk in Communities Study. Stroke. 2010;41:1349\u201355.","journal-title":"Stroke"},{"key":"638_CR22","doi-asserted-by":"publisher","first-page":"e0214685","DOI":"10.1371\/journal.pone.0214685","volume":"14","author":"YS Zhang","year":"2019","unstructured":"Zhang YS, Zhou N, Knoll BM, et al. Parafoveal vessel loss and correlation between peripapillary vessel density and cognitive performance in amnestic mild cognitive impairment and early Alzheimer\u2019s disease on optical coherence tomography angiography. PLoS One. 2019;14:e0214685.","journal-title":"PLoS One"},{"key":"638_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ophtha.2018.08.009","volume":"126","author":"VTT Chan","year":"2019","unstructured":"Chan VTT, Sun Z, Tang S, et al. Spectral-domain OCT measurements in Alzheimer\u2019s disease: a systematic review and meta-analysis. Ophthalmology. 2019;126:497\u2013510.","journal-title":"Ophthalmology"},{"key":"638_CR24","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/s41598-020-58399-4","volume":"10","author":"D Sanchez","year":"2020","unstructured":"Sanchez D, Castilla-Marti M, Marquie M, et al. Evaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer\u2019s disease in a memory clinic. Sci Rep. 2020;10:1580.","journal-title":"Sci Rep"},{"key":"638_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","volume":"9","author":"A London","year":"2013","unstructured":"London A, Benhar I, Schwartz M. The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol. 2013;9:44\u201353.","journal-title":"Nat Rev Neurol"},{"key":"638_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13195-019-0516-x","volume":"11","author":"J den Haan","year":"2019","unstructured":"den Haan J, Csinscik L, Parker T, et al. Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer\u2019s disease. Alzheimers Res Ther. 2019;11:62.","journal-title":"Alzheimers Res Ther"},{"key":"638_CR27","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1177\/1533317515628053","volume":"31","author":"JA Pillai","year":"2016","unstructured":"Pillai JA, Bermel R, Bonner-Jackson A, et al. Retinal nerve fiber layer thinning in Alzheimer\u2019s disease: a case-control study in comparison to normal aging, Parkinson\u2019s disease, and non-Alzheimer\u2019s dementia. Am J Alzheimers Dis Other Dement. 2016;31:430\u20136.","journal-title":"Am J Alzheimers Dis Other Dement"},{"key":"638_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jalz.2013.06.009","volume":"10","author":"C CY-l","year":"2014","unstructured":"CY-l C, Ong YT, Ikram MK, et al. Microvascular network alterations in the retina of patients with Alzheimer\u2019s disease. Alzheimers Dement. 2014;10:135\u201342.","journal-title":"Alzheimers Dement"},{"key":"638_CR29","doi-asserted-by":"publisher","first-page":"e0184301","DOI":"10.1371\/journal.pone.0184301","volume":"12","author":"R Igarashi","year":"2017","unstructured":"Igarashi R, Ochiai S, Sakaue Y, et al. Optical coherence tomography angiography of the peripapillary capillaries in primary open-angle and normal-tension glaucoma. PLoS One. 2017;12:e0184301.","journal-title":"PLoS One"},{"key":"638_CR30","doi-asserted-by":"publisher","first-page":"e0157388","DOI":"10.1371\/journal.pone.0157388","volume":"11","author":"JY Lee","year":"2016","unstructured":"Lee JY, Cho K, Park KA, Oh SY. Analysis of retinal layer thicknesses and their clinical correlation in patients with traumatic optic neuropathy. PLoS One. 2016;11:e0157388.","journal-title":"PLoS One"},{"key":"638_CR31","doi-asserted-by":"publisher","first-page":"e0190621","DOI":"10.1371\/journal.pone.0190621","volume":"13","author":"V Kansal","year":"2018","unstructured":"Kansal V, Armstrong JJ, Pintwala R, Hutnik C. Optical coherence tomography for glaucoma diagnosis: an evidence based meta-analysis. PLoS One. 2018;13:e0190621.","journal-title":"PLoS One"},{"key":"638_CR32","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.ophtha.2014.01.034","volume":"121","author":"Y Jia","year":"2014","unstructured":"Jia Y, Bailey ST, Wilson DJ, et al. Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. Ophthalmology. 2014;121:1435\u201344.","journal-title":"Ophthalmology"},{"key":"638_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1001\/jamaophthalmol.2014.3616","volume":"133","author":"RF Spaide","year":"2015","unstructured":"Spaide RF, Klancnik JM Jr, Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 2015;133:45\u201350.","journal-title":"JAMA Ophthalmol"},{"key":"638_CR34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/bjophthalmol-2017-310476","volume":"102","author":"M Bulut","year":"2018","unstructured":"Bulut M, Kurtulus F, Gozkaya O, et al. Evaluation of optical coherence tomography angiographic findings in Alzheimer\u2019s type dementia. Br J Ophthalmol. 2018;102:233\u20137.","journal-title":"Br J Ophthalmol"},{"key":"638_CR35","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3233\/JAD-180738","volume":"66","author":"L Lahme","year":"2018","unstructured":"Lahme L, Esser EL, Mihailovic N, et al. Evaluation of ocular perfusion in Alzheimer\u2019s disease using optical coherence tomography angiography. J Alzheimer\u2019s Dis. 2018;66:1745\u201352.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"638_CR36","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/WNO.0000000000000580","volume":"38","author":"H Jiang","year":"2018","unstructured":"Jiang H, Wei Y, Shi Y, et al. Altered macular microvasculature in mild cognitive impairment and Alzheimer disease. J Neuroophthalmol. 2018;38:292\u20138.","journal-title":"J Neuroophthalmol"},{"key":"638_CR37","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1001\/jamaophthalmol.2018.3556","volume":"136","author":"BE O\u2019Bryhim","year":"2018","unstructured":"O\u2019Bryhim BE, Apte RS, Kung N, Coble D, Van Stavern GP. Association of preclinical Alzheimer disease with optical coherence tomographic angiography findings. JAMA Ophthalmol. 2018;136:1242\u20138.","journal-title":"JAMA Ophthalmol"},{"key":"638_CR38","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/brain\/awh688","volume":"129","author":"MK Ikram","year":"2006","unstructured":"Ikram MK, De Jong FJ, Van Dijk EJ, et al. Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study. Brain. 2006;129:182\u20138.","journal-title":"Brain"},{"key":"638_CR39","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.dadm.2016.12.014","volume":"6","author":"J den Haan","year":"2017","unstructured":"den Haan J, Verbraak FD, Visser PJ, Bouwman FH. Retinal thickness in Alzheimer\u2019s disease: a systematic review and meta-analysis. Alzheimers Dement (Amst). 2017;6:162\u201370.","journal-title":"Alzheimers Dement (Amst)"},{"key":"638_CR40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"638_CR41","doi-asserted-by":"crossref","unstructured":"Kang SH, Park YH, Lee D, et al. The cortical neuroanatomy related to specific neuropsychological deficits in Alzheimer\u2019s continuum. Dement Neurocogn Disord. 2019;18:77\u201395.","DOI":"10.12779\/dnd.2019.18.3.77"},{"key":"638_CR42","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1001\/jamapsychiatry.2013.4506","volume":"71","author":"MJ Lee","year":"2014","unstructured":"Lee MJ, Seo SW, Na DL, et al. Synergistic effects of ischemia and \u03b2-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment. JAMA psychiatry. 2014;71:412\u201322.","journal-title":"JAMA psychiatry"},{"key":"638_CR43","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jalz.2014.04.521","volume":"11","author":"BS Ye","year":"2015","unstructured":"Ye BS, Seo SW, Kim GH, et al. Amyloid burden, cerebrovascular disease, brain atrophy, and cognition in cognitively impaired patients. Alzheimer\u2019s Dement. 2015;11:494\u2013503.e493.","journal-title":"Alzheimer\u2019s Dement"},{"key":"638_CR44","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/jamaneurol.2018.0975","volume":"75","author":"HJ Kim","year":"2018","unstructured":"Kim HJ, Park S, Cho H, et al. Assessment of extent and role of tau in subcortical vascular cognitive impairment using 18F-AV1451 positron emission tomography imaging. JAMA Neurol. 2018;75:999\u20131007.","journal-title":"JAMA Neurol"},{"key":"638_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40942-017-0068-9","volume":"3","author":"M Al-Sheikh","year":"2017","unstructured":"Al-Sheikh M, Ghasemi Falavarjani K, Akil H, Sadda SR. Impact of image quality on OCT angiography based quantitative measurements. Int J Retina Vitreous. 2017;3:13.","journal-title":"Int J Retina Vitreous"},{"key":"638_CR46","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1167\/iovs.05-0352","volume":"46","author":"MN Menke","year":"2005","unstructured":"Menke MN, Feke GT, Trempe CL. OCT measurements in patients with optic disc edema. Invest Ophthalmol Vis Sci. 2005;46:3807\u201311.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"638_CR47","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1001\/jamaophthalmol.2015.2225","volume":"133","author":"L Liu","year":"2015","unstructured":"Liu L, Jia Y, Takusagawa HL, et al. Optical coherence tomography angiography of the peripapillary retina in glaucoma. JAMA Ophthalmol. 2015;133:1045\u201352.","journal-title":"JAMA Ophthalmol"},{"key":"638_CR48","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1006\/nimg.2000.0652","volume":"13","author":"N Kabani","year":"2001","unstructured":"Kabani N, Le Goualher G, MacDonald D, Evans AC. Measurement of cortical thickness using an automated 3-D algorithm: a validation study. Neuroimage. 2001;13:375\u201380.","journal-title":"Neuroimage"},{"key":"638_CR49","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.neuroimage.2005.12.044","volume":"31","author":"JK Lee","year":"2006","unstructured":"Lee JK, Lee J-M, Kim JS, Kim IY, Evans AC, Kim SI. A novel quantitative cross-validation of different cortical surface reconstruction algorithms using MRI phantom. Neuroimage. 2006;31:572\u201384.","journal-title":"Neuroimage"},{"key":"638_CR50","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S1474-4422(09)70013-4","volume":"8","author":"SM Greenberg","year":"2009","unstructured":"Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8:165\u201374.","journal-title":"Lancet Neurol"},{"key":"638_CR51","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S1474-4422(11)70077-1","volume":"10","author":"H Barthel","year":"2011","unstructured":"Barthel H, Gertz HJ, Dresel S, et al. Cerebral amyloid-beta PET with florbetaben (18F) in patients with Alzheimer\u2019s disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol. 2011;10:424\u201335.","journal-title":"Lancet Neurol"},{"key":"638_CR52","first-page":"1250","volume":"58","author":"G Farrar","year":"2017","unstructured":"Farrar G. Regional visual read inspection of [18F] flutemetamol brain images from end-of-life and amnestic MCI subjects. J Nucl Med. 2017;58:1250.","journal-title":"J Nucl Med"},{"key":"638_CR53","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.dadm.2019.03.006","volume":"11","author":"JD Haan","year":"2019","unstructured":"Haan JD, van de Kreeke JA, van Berckel BN, et al. Is retinal vasculature a biomarker in amyloid proven Alzheimer\u2019s disease? Alzheimers Dement (Amst). 2019;11:383\u201391.","journal-title":"Alzheimers Dement (Amst)"},{"key":"638_CR54","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1212\/01.WNL.0000033093.16450.5C","volume":"59","author":"VI Kwa","year":"2002","unstructured":"Kwa VI, van der Sande JJ, Stam J, Tijmes N, Vrooland JL. Retinal arterial changes correlate with cerebral small-vessel disease. Neurology. 2002;59:1536\u201340.","journal-title":"Neurology"},{"issue":"Pt 2","key":"638_CR55","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/eye.1990.39","volume":"4","author":"SS Hayreh","year":"1990","unstructured":"Hayreh SS. In vivo choroidal circulation and its watershed zones. Eye (Lond). 1990;4(Pt 2):273\u201389.","journal-title":"Eye (Lond)"},{"key":"638_CR56","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14:535\u201362.","journal-title":"Alzheimers Dement"},{"key":"638_CR57","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement. 2018;4:575\u201390.","journal-title":"Alzheimers Dement"},{"key":"638_CR58","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.2337\/db07-1455","volume":"57","author":"C Qiu","year":"2008","unstructured":"Qiu C, Cotch MF, Sigurdsson S, et al. Retinal and cerebral microvascular signs and diabetes: the Age, Gene\/Environment Susceptibility-Reykjavik Study. Diabetes. 2008;57:1645\u201350.","journal-title":"Diabetes"},{"key":"638_CR59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fpsyt.2014.00022","volume":"5","author":"R Kromer","year":"2014","unstructured":"Kromer R, Serbecic N, Hausner L, Froelich L, Aboul-Enein F, Beutelspacher SC. Detection of retinal nerve fiber layer defects in Alzheimer\u2019s disease using SD-OCT. Front Psychiatry. 2014;5:22.","journal-title":"Front Psychiatry"},{"key":"638_CR60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.dadm.2017.10.005","volume":"10","author":"J den Haan","year":"2018","unstructured":"den Haan J, Janssen SF, van de Kreeke JA, Scheltens P, Verbraak FD, Bouwman FH. Retinal thickness correlates with parietal cortical atrophy in early-onset Alzheimer\u2019s disease and controls. Alzheimers Dement (Amst). 2018;10:49\u201355.","journal-title":"Alzheimers Dement (Amst)"},{"key":"638_CR61","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/aos.14121","volume":"97","author":"JA van de Kreeke","year":"2019","unstructured":"van de Kreeke JA, Nguyen HT, den Haan J, et al. Retinal layer thickness in preclinical Alzheimer\u2019s disease. Acta Ophthalmol. 2019;97:798\u2013804.","journal-title":"Acta Ophthalmol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00638-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-020-00638-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00638-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T23:49:04Z","timestamp":1623368944000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-020-00638-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,11]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["638"],"URL":"https:\/\/doi.org\/10.1186\/s13195-020-00638-x","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,11]]},"assertion":[{"value":"24 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The institutional review boards at all participating centers approved this study, and informed consent was obtained from the patients and caregivers.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}